Subscribe
shutterstock_1176271219_ivan_marc
Ivan Marc / Shutterstock.com
8 July 2019EuropeSarah Morgan

EMA settles Brexit dispute; issues drug shortages guidance

The European Medicines Agency (EMA) has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
No-deal Brexit: MHRA would take on EMA functions for UK
24 August 2018   The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market.
Big Pharma
London loses EMA to Amsterdam
21 November 2017   The European Medicines Agency will relocate from its London, UK headquarters to Amsterdam, in the Netherlands.
Big Pharma
Pharma bodies sign NDAs with UK govt over no-deal Brexit plans
16 August 2019   Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Big Pharma
No-deal Brexit: MHRA would take on EMA functions for UK
24 August 2018   The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market.
Big Pharma
London loses EMA to Amsterdam
21 November 2017   The European Medicines Agency will relocate from its London, UK headquarters to Amsterdam, in the Netherlands.
Big Pharma
Pharma bodies sign NDAs with UK govt over no-deal Brexit plans
16 August 2019   Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

More on this story

Big Pharma
No-deal Brexit: MHRA would take on EMA functions for UK
24 August 2018   The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market.
Big Pharma
London loses EMA to Amsterdam
21 November 2017   The European Medicines Agency will relocate from its London, UK headquarters to Amsterdam, in the Netherlands.
Big Pharma
Pharma bodies sign NDAs with UK govt over no-deal Brexit plans
16 August 2019   Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool
USPTO clarifies AI's role in patent eligibility